Molecular Partners AG at JPMorgan Healthcare Conference Transcript
Good morning, everybody. I'm James Quigley, European Pharma and Biotech Analyst from JPMorgan. It's my pleasure to welcome you to the Molecular Partners presentation. With us today is the CEO, Patrick Amstutz. After Patrick's presentation, we've got a breakout session in the Kent Room. So we come out here, head down the hall and go as far as you can, that's the Kent Room. So with that, over to you, Patrick.
Thanks, James, for the nice introduction. Thanks to everyone coming here. The weather today, it's not so good. So some have wet feet, special thanks to those waiting through the rivers out there. I want to also thank the people on the webcast listening in. As a Swiss company, we also have people, obviously, from also Switzerland, who will be listening in now. So at Molecular Partners, we worked very hard in the last year in-house, but also with our partners to align the stars for 2020
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
